Multiple myeloma with multiple and bulky extramedullary plasmacytomas as initial presentation. 2009

Takeshi SAWADA, and Yuho NAJIMA, and Kazuteru OHASHI, and Ikuma KATO, and Maho MIYAZAWA, and Mikako NAKANO, and Takeshi KOBAYASHI, and Takuya YAMASHITA, and Hideki AKIYAMA, and Hisashi SAKAMAKI
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital.

We herein describe a rare case of multiple myeloma with an aggressive clinical course and the unusual manifestation of multiple organ involvement by plasma cells. A 58-year-old man noted difficulty in walking due to progressive swelling of his left lower limb. CT scan revealed a huge mass in the inguinal region in addition to masses located on the head, and in the aero-digestive tract and spinal canal. The pathological diagnosis of plasmacytoma was made on biopsied specimens of these masses, while plasma cells did not increase (5.8%) in aspirated bone marrow obtained at the same time. Serum IgG level was 6,387 mg/dl and immunoelectrophoresis demonstrated monoclonal IgG-kappa in the serum. Chemotherapy with vincristine, adriamycin, dexamethasone, subsequent high-dose cyclophosphamide, and irradiation involving both thoracic vertebral canal and inguinal regions resulted in improvement of initial symptoms. However, the patient relapsed soon after; new lesions developed in various parts of the body, including the left thigh and body trunk. Salvage therapy including bortezomib was no longer effective, and he eventually died 10 months after the initial diagnosis. Autopsy revealed the diffuse involvement of plasma cells of multiple organs, including the liver, spleen, abdominal lymph node, and bone marrow in addition to the left leg.

UI MeSH Term Description Entries
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D011719 Pyrazines A heterocyclic aromatic organic compound with the chemical formula C4H4N2. Pyrazine
D001897 Boronic Acids Inorganic or organic compounds that contain the basic structure RB(OH)2. Boronic Acid,Acid, Boronic,Acids, Boronic
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069286 Bortezomib A pyrazine and boronic acid derivative that functions as a reversible PROTEASOME INHIBITOR. It is used as an ANTINEOPLASTIC AGENT in the treatment of MULTIPLE MYELOMA and MANTLE CELL LYMPHOMA. LDP-341,PS 341,PS-341,Velcade,341, PS,LDP 341,LDP341,PS341

Related Publications

Takeshi SAWADA, and Yuho NAJIMA, and Kazuteru OHASHI, and Ikuma KATO, and Maho MIYAZAWA, and Mikako NAKANO, and Takeshi KOBAYASHI, and Takuya YAMASHITA, and Hideki AKIYAMA, and Hisashi SAKAMAKI
October 2008, Annals of hematology,
Takeshi SAWADA, and Yuho NAJIMA, and Kazuteru OHASHI, and Ikuma KATO, and Maho MIYAZAWA, and Mikako NAKANO, and Takeshi KOBAYASHI, and Takuya YAMASHITA, and Hideki AKIYAMA, and Hisashi SAKAMAKI
November 1966, British medical journal,
Takeshi SAWADA, and Yuho NAJIMA, and Kazuteru OHASHI, and Ikuma KATO, and Maho MIYAZAWA, and Mikako NAKANO, and Takeshi KOBAYASHI, and Takuya YAMASHITA, and Hideki AKIYAMA, and Hisashi SAKAMAKI
August 2011, Clinical advances in hematology & oncology : H&O,
Takeshi SAWADA, and Yuho NAJIMA, and Kazuteru OHASHI, and Ikuma KATO, and Maho MIYAZAWA, and Mikako NAKANO, and Takeshi KOBAYASHI, and Takuya YAMASHITA, and Hideki AKIYAMA, and Hisashi SAKAMAKI
June 2010, The Korean journal of hematology,
Takeshi SAWADA, and Yuho NAJIMA, and Kazuteru OHASHI, and Ikuma KATO, and Maho MIYAZAWA, and Mikako NAKANO, and Takeshi KOBAYASHI, and Takuya YAMASHITA, and Hideki AKIYAMA, and Hisashi SAKAMAKI
March 2011, Journal of gastrointestinal and liver diseases : JGLD,
Takeshi SAWADA, and Yuho NAJIMA, and Kazuteru OHASHI, and Ikuma KATO, and Maho MIYAZAWA, and Mikako NAKANO, and Takeshi KOBAYASHI, and Takuya YAMASHITA, and Hideki AKIYAMA, and Hisashi SAKAMAKI
August 2010, Oncology (Williston Park, N.Y.),
Takeshi SAWADA, and Yuho NAJIMA, and Kazuteru OHASHI, and Ikuma KATO, and Maho MIYAZAWA, and Mikako NAKANO, and Takeshi KOBAYASHI, and Takuya YAMASHITA, and Hideki AKIYAMA, and Hisashi SAKAMAKI
March 2012, Zhonghua yi xue za zhi,
Takeshi SAWADA, and Yuho NAJIMA, and Kazuteru OHASHI, and Ikuma KATO, and Maho MIYAZAWA, and Mikako NAKANO, and Takeshi KOBAYASHI, and Takuya YAMASHITA, and Hideki AKIYAMA, and Hisashi SAKAMAKI
April 2023, Journal of the Formosan Medical Association = Taiwan yi zhi,
Takeshi SAWADA, and Yuho NAJIMA, and Kazuteru OHASHI, and Ikuma KATO, and Maho MIYAZAWA, and Mikako NAKANO, and Takeshi KOBAYASHI, and Takuya YAMASHITA, and Hideki AKIYAMA, and Hisashi SAKAMAKI
January 2015, Case reports in hematology,
Takeshi SAWADA, and Yuho NAJIMA, and Kazuteru OHASHI, and Ikuma KATO, and Maho MIYAZAWA, and Mikako NAKANO, and Takeshi KOBAYASHI, and Takuya YAMASHITA, and Hideki AKIYAMA, and Hisashi SAKAMAKI
November 2011, Advances in therapy,
Copied contents to your clipboard!